Discover how a revolutionary 3D Blood-Brain Barrier model advances the understanding of neurodegenerative diseases and drug ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Being a Cantonese Singaporean, Traditional Chinese Medicine (TCM) has always been in my life (and the world’s for the past ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Carnegie Mellon University neuroscientists have discovered connections between the globus pallidus and a rarely explored area of the brain.

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

Tumor-Secreted Protein May Hold the Key to Better Treatments for Deadly Brain Tumor Jan. 8, 2025 — A study has found targeting a protein called endocan and its related signaling pathway could be ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

A “life changing” treatment that uses implanted electrodes to stimulate muscles and relieve chronic low back pain is now ...

Belief is your safe passage—the door through which all healing resides. Why? Because your perception is your reality. Believing in the science of TMS ( tension myositis syndrome) sends a message of ...

scientists can predict which patients will develop chronic pain based on the extent of cross 'talk' between two regions of the brain, and ... Oct. 22, 2024 — In a study, researchers use ...

The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...